专题：Alcohol Consumption and Health Effects

This cluster of papers focuses on the pathogenesis, treatment, and impact of alcohol consumption on the development of alcoholic liver disease. It covers topics such as oxidative stress, cancer risk, inflammation, genetic polymorphisms, cardiovascular health, and mortality risk associated with alcohol consumption.
最新文献
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

article Full Text OpenAlex

Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023

article Full Text OpenAlex

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study

article Full Text OpenAlex

Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management

review Full Text OpenAlex

ACG Clinical Guideline: Hepatic Encephalopathy

article Full Text OpenAlex

Association of the C-reactive protein–triglyceride–glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies

article Full Text OpenAlex

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management

review Full Text OpenAlex

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis

article Full Text OpenAlex

The Multidirectional Biological Activity of Resveratrol: Molecular Mechanisms, Systemic Effects and Therapeutic Potential—A Review

review Full Text OpenAlex

Association of cholesterol, high-density lipoprotein and glucose (CHG) index with mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) adults: results from two prospective cohorts

article Full Text OpenAlex

近5年高被引文献
A multisociety Delphi consensus statement on new fatty liver disease nomenclature

article Full Text OpenAlex 3454 FWCI689.2779

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

review Full Text OpenAlex 3367 FWCI132.4116

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

review Full Text OpenAlex 3090 FWCI121.1877

Global burden of liver disease: 2023 update

review Full Text OpenAlex 2258 FWCI103.1586

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

review Full Text OpenAlex 2235 FWCI71.9346

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

article Full Text OpenAlex 2184 FWCI671.0661

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

article Full Text OpenAlex 1018 FWCI150.0639

Epidemiology of metabolic dysfunction-associated steatotic liver disease

review Full Text OpenAlex 947 FWCI62.8096

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

review Full Text OpenAlex 924 FWCI61.2841

Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss

review Full Text OpenAlex 909 FWCI29.6949